We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

93 hedge funds and large institutions have $238M invested in Utah Medical Products in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

27% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 26

3% more funds holding

Funds holding: 90 → 93 (+3)

2.92% more ownership

Funds ownership: 71.07% → 73.99% (+2.9%)

4% less capital invested

Capital invested by funds: $247M → $238M (-$9.01M)

Holders
93
Holders Change
+3
Holders Change %
+3.33%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
33
Reduced
26
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.1M
2
JP Morgan Chase
JP Morgan Chase
New York
+$2.62M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.53M
4
Millennium Management
Millennium Management
New York
+$1.88M
5
HR
Hayden Royal
North Carolina
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
ProShare Advisors
ProShare Advisors
Maryland
-$11.6M
2
AA
Ancora Advisors
Ohio
-$848K
3
UBS Group
UBS Group
Switzerland
-$812K
4
TAM
THB Asset Management
Connecticut
-$801K
5
KFA
Krane Funds Advisors
New York
-$721K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$48.4M +$10.1M +112,808 +26%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$26M -$459K -5,115 -2%
Renaissance Technologies
3
Renaissance Technologies
New York
$20.7M +$197K +2,200 +1%
BlackRock
4
BlackRock
New York
$19.6M -$260K -2,900 -1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$15.4M -$449 -5 -0%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$15M -$70.5K -785 -0.5%
Russell Investments Group
7
Russell Investments Group
United Kingdom
$13M +$910K +10,138 +7%
State Street
8
State Street
Massachusetts
$6.83M +$90.5K +1,008 +1%
RHJA
9
Rice Hall James & Associates
California
$6.41M +$60.1K +670 +0.9%
RIM
10
Ranger Investment Management
Texas
$5.96M +$125K +1,395 +2%
Northern Trust
11
Northern Trust
Illinois
$5.06M -$26.9K -300 -0.5%
AA
12
Ancora Advisors
Ohio
$4.69M -$848K -9,446 -15%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$4.64M +$73.5K +819 +2%
JP Morgan Chase
14
JP Morgan Chase
New York
$3.98M +$2.62M +29,182 +185%
Loomis, Sayles & Company
15
Loomis, Sayles & Company
Massachusetts
$3.34M +$498K +5,545 +17%
RA
16
Royce & Associates
New York
$2.95M +$269 +3 +0%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$2.5M +$2.53M +28,160 New
CYG
18
Clean Yield Group
Vermont
$2.31M -$129K -1,435 -5%
MAM
19
Martingale Asset Management
Massachusetts
$2.13M +$26.9K +300 +1%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$2.03M +$68.5K +763 +3%
Millennium Management
21
Millennium Management
New York
$1.85M +$1.88M +20,905 New
RJA
22
Raymond James & Associates
Florida
$1.49M +$41.6K +463 +3%
Charles Schwab
23
Charles Schwab
California
$1.48M +$307K +3,417 +26%
Natixis Advisors
24
Natixis Advisors
Massachusetts
$1.37M +$335K +3,727 +32%
AQR Capital Management
25
AQR Capital Management
Connecticut
$1.25M -$20.2K -225 -2%
1
2 3 4 5

UTMD Hedge Fund Activity: Q2 2020 in Review

93 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2020, worth a combined $238M — down 3.6% from $247M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new UTMD positions and 9 closed out — a net gain of 3 holders — while 33 added to existing stakes and 26 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.1M. The largest seller was ProShare Advisors, exiting entirely with an estimated $11.6M sold.

  • 93 institutional investors held Utah Medical Products (UTMD) as of Q2 2020, up from 90 in Q1 2020.
  • Funds reported $238M of Utah Medical Products stock for Q2 2020, down 3.6% quarter-over-quarter.
  • 12 funds opened new Utah Medical Products positions in Q2 2020 and 9 closed out, a net change of +3 holders.
  • The largest Utah Medical Products buyer in Q2 2020 was Fidelity Investments, an estimated $10.1M added.
  • The largest Utah Medical Products seller in Q2 2020 was ProShare Advisors, an estimated $11.6M sold.

Based on aggregated 13F filings for Q2 2020.